Top Story

Late mortality, morbidity rates increase among survivors of adult Hodgkin's lymphoma

March 27, 2015

Survivors of adult Hodgkin’s lymphoma face high risks for late mortality from other causes, as well as late medical morbidity, according to study results.

Medical advances have greatly improved survival for patients with Hodgkin’s lymphoma. However, as survivorship increases, the effects of late treatment-related complications are becoming more apparent.

Breaking News

Senate adjourns without voting on bill to repeal sustainable growth rate

March 27, 2015
The U.S. Senate left for its 2-week spring break without voting on a bill that repeals the sustainable growth rate, leaving physicians to face a 21% payment cut if…
FDA News

FDA grants orphan drug designation to CRS-207 for mesothelioma

March 27, 2015
The FDA granted orphan drug designation to CRS-207 — a novel immuno-oncology product candidate — for the treatment of patients with malignant pleural…
Guy Young, MD In the Journals

Investigation programs needed for study of risks in use of pediatric anticoagulant drugs

March 27, 2015
The International Society on Thrombosis and Haemostasis called for the development of pediatric investigative programs to study risks of anticoagulants in children and…
Meeting News Coverage

History of cancer cited among risk factors for failure of flap coverage in revision TKA

March 27, 2015
LAS VEGAS — A retrospective review presented here of 43 flaps used for coverage of soft tissue defects in revision total knee arthroplasty identifies risk factors…
More News Headlines »
Stem Cell Transplant for AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 3 Stem Cell Transplant for MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »
Meeting News Coverage Video
thumbnail for video 4124118507001

3D printing has applications, challenges in a variety of medical specialties

March 20, 2015
SAN FRANCISCO — Scott Hollister, PhD, professor of biomedical engineering at the University of Michigan, talks…
More »
Activity cover

Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates

This activity is supported by an educational grant from Merck & Co., Inc.

Melanoma remains a challenging condition for clinicians. An array of targeted therapies and immunotherapy are in…
More »